Wortmannin (Wtmn), a PI3K inhibitor, was further used in this experiment to observe the effect of the PI3K/AKT pathway in the cisplatin-induced AKI mouse model and further understand the protective effect of WFV. Here, AKT1 is linked to acute kidney injury.